Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.7 |
mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | -0.022 | 0.7 |
mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.02 | 0.7 |
mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.7 |
mRNA | 681640 | GDSC1000 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.7 |
mRNA | Bryostatin 1 | FIMM | pan-cancer | AAC | -0.075 | 0.7 |
mRNA | SGC0946 | GDSC1000 | pan-cancer | AAC | 0.015 | 0.7 |